sigmoidal dose–response curves generated for each b-cll patient using the software program prism (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
sigmoidal dose–response curves generated for each b-cll patient using the software program prism
Sigmoidal Dose–Response Curves Generated For Each B Cll Patient Using The Software Program Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmoidal+dose%E2%80%93response+curves+generated+for+each+b-cll+patient+using+the+software+program+prism/sigmoidal+dose+response+curves+generated+for+each+b+cll+patient+using+the+software+program+prism/pm15382079-65-23-25
Average 90 stars, based on 1 article reviews
Sigmoidal Dose–Response Curves Generated For Each B Cll Patient Using The Software Program Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmoidal+dose%E2%80%93response+curves+generated+for+each+b-cll+patient+using+the+software+program+prism/sigmoidal+dose+response+curves+generated+for+each+b+cll+patient+using+the+software+program+prism/pm15382079-65-23-25
Average 90 stars, based on 1 article reviews
sigmoidal dose–response curves generated for each b-cll patient using the software program prism - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Lysis:Article Title: Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells. Article Snippet: To develop an effective antitumor immunotherapy for Blineage non-Hodgkin’s lymphoma, we constructed a tetravalent tandem diabody (tanDb) specific for both human CD19 (B-cell marker) and CD3 (T-cell antigen).. Here, we report the effective killing of malignant primary B cells from patients with B-cell chronic lymphocytic leukemia (B-CLL) by autologous T cells induced by tanDb at very low E:T ratios.. Mononuclear cells from patients with B-CLL were cultured with bispecific antibody fragments in either the presence or absence of monospecific anti-CD28 antibody. Generated:Article Title: Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells. Article Snippet: To develop an effective antitumor immunotherapy for Blineage non-Hodgkin’s lymphoma, we constructed a tetravalent tandem diabody (tanDb) specific for both human CD19 (B-cell marker) and CD3 (T-cell antigen).. Here, we report the effective killing of malignant primary B cells from patients with B-cell chronic lymphocytic leukemia (B-CLL) by autologous T cells induced by tanDb at very low E:T ratios.. Mononuclear cells from patients with B-CLL were cultured with bispecific antibody fragments in either the presence or absence of monospecific anti-CD28 antibody. Software:Article Title: Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells. Article Snippet: To develop an effective antitumor immunotherapy for Blineage non-Hodgkin’s lymphoma, we constructed a tetravalent tandem diabody (tanDb) specific for both human CD19 (B-cell marker) and CD3 (T-cell antigen).. Here, we report the effective killing of malignant primary B cells from patients with B-cell chronic lymphocytic leukemia (B-CLL) by autologous T cells induced by tanDb at very low E:T ratios.. Mononuclear cells from patients with B-CLL were cultured with bispecific antibody fragments in either the presence or absence of monospecific anti-CD28 antibody. |